Related Experiment Video
Updated: Jun 18, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
Published on: May 21, 2008
Steve Reed. Interviewed by Charlotte Schubert
1Nature Medicine, Washington, DC, USA.
Abstract:
Steve Reed believes the organization he has founded has the potential to radically increase the developing world's access to vaccines for neglected diseases. The efforts of the Seattle-based Infectious Disease Research Institute (IDRI), which operates as a not-for-profit biotech company, may start to pay off during the H1N1 'swine' flu pandemic. IDRI developed an adjuvant to boost the effectiveness and supplies of flu vaccines and is making the technology available to vaccine manufacturers in developing nations. Charlotte Schubert talks to Reed about how IDRI, a 90-person operation with a $19 million annual budget, could have such a big impact.
Related Concept Videos
Stereotype Threat and Self-fulfilling Prophecies
Impression Management Techniques IV: Altercasting
Schottky Barrier Diode
Introduction to Nuclear Reprogramming
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Reproductive Cloning
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic cell—any cell that is not a sex...

